nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXAS1—mammary gland—breast cancer	0.0415	0.165	CbGeAlD
Ridogrel—TBXA2R—epithelium—breast cancer	0.0263	0.105	CbGeAlD
Ridogrel—TBXA2R—adipose tissue—breast cancer	0.0213	0.0848	CbGeAlD
Ridogrel—TBXA2R—female reproductive system—breast cancer	0.0195	0.0779	CbGeAlD
Ridogrel—TBXAS1—uterus—breast cancer	0.0191	0.0761	CbGeAlD
Ridogrel—TBXA2R—adrenal gland—breast cancer	0.0191	0.076	CbGeAlD
Ridogrel—TBXAS1—adipose tissue—breast cancer	0.0187	0.0744	CbGeAlD
Ridogrel—TBXAS1—adrenal gland—breast cancer	0.0167	0.0667	CbGeAlD
Ridogrel—TBXA2R—endocrine gland—breast cancer	0.0165	0.0659	CbGeAlD
Ridogrel—TBXAS1—bone marrow—breast cancer	0.0162	0.0646	CbGeAlD
Ridogrel—TBXAS1—endocrine gland—breast cancer	0.0145	0.0579	CbGeAlD
Ridogrel—TBXA2R—lymph node—breast cancer	0.0114	0.0456	CbGeAlD
Ridogrel—TBXAS1—lymph node—breast cancer	0.01	0.04	CbGeAlD
Ridogrel—Niflumic Acid—PLA2G4A—breast cancer	0.00758	0.332	CrCbGaD
Ridogrel—Fluvoxamine—CYP1A1—breast cancer	0.00375	0.164	CrCbGaD
Ridogrel—Fluvoxamine—CYP2D6—breast cancer	0.00279	0.122	CrCbGaD
Ridogrel—Niflumic Acid—PTGS1—breast cancer	0.00277	0.121	CrCbGaD
Ridogrel—Fluvoxamine—CYP3A4—breast cancer	0.00239	0.105	CrCbGaD
Ridogrel—Fluvoxamine—ABCB1—breast cancer	0.00199	0.0871	CrCbGaD
Ridogrel—Niflumic Acid—PTGS2—breast cancer	0.00158	0.0692	CrCbGaD
Ridogrel—TBXAS1—Metabolism—SLC2A2—breast cancer	0.000417	0.000574	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRLR—breast cancer	0.000413	0.000568	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.000413	0.000568	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PLAU—breast cancer	0.000412	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CDK2—breast cancer	0.000412	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL12—breast cancer	0.000412	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCR4—breast cancer	0.000412	0.000567	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	0.000411	0.000566	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ABCG2—breast cancer	0.000409	0.000563	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CPT1A—breast cancer	0.000409	0.000563	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTR—breast cancer	0.000409	0.000563	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CAV1—breast cancer	0.000403	0.000554	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—MAPK3—breast cancer	0.000402	0.000554	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HPGDS—breast cancer	0.000401	0.000552	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VCP—breast cancer	0.000399	0.000549	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GLI2—breast cancer	0.000399	0.000549	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HBA1—breast cancer	0.000398	0.000548	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	0.000397	0.000546	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LEPR—breast cancer	0.000392	0.00054	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	0.000391	0.000539	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—breast cancer	0.00039	0.000538	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTT1—breast cancer	0.000389	0.000535	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ACHE—breast cancer	0.000389	0.000535	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—FN1—breast cancer	0.000383	0.000527	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CALCA—breast cancer	0.000383	0.000527	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—PIK3CA—breast cancer	0.00038	0.000523	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NOS2—breast cancer	0.000379	0.000521	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCR4—breast cancer	0.000374	0.000515	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL12—breast cancer	0.000374	0.000515	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR1—breast cancer	0.000372	0.000513	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	0.00037	0.000509	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP17A1—breast cancer	0.000368	0.000506	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CG—breast cancer	0.000367	0.000505	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ARHGDIA—breast cancer	0.000365	0.000502	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ENO1—breast cancer	0.000364	0.000501	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTGS1—breast cancer	0.000364	0.000501	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000363	0.0005	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EGF—breast cancer	0.000362	0.000499	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.000358	0.000493	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP2D6—breast cancer	0.000357	0.000492	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FST—breast cancer	0.000355	0.000489	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HEY2—breast cancer	0.000351	0.000483	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA2—breast cancer	0.000351	0.000483	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RPS6KB2—breast cancer	0.000347	0.000477	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RGS2—breast cancer	0.000343	0.000472	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—FASN—breast cancer	0.00034	0.000468	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	0.00034	0.000468	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCL20—breast cancer	0.000339	0.000467	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—BCHE—breast cancer	0.000339	0.000466	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR1—breast cancer	0.000338	0.000466	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IGF1—breast cancer	0.000336	0.000462	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT2—breast cancer	0.000335	0.000462	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC5A5—breast cancer	0.000334	0.00046	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ITPR1—breast cancer	0.000334	0.00046	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	0.000332	0.000457	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LPAR1—breast cancer	0.000328	0.000452	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TLE3—breast cancer	0.000328	0.000452	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HEY1—breast cancer	0.000325	0.000447	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC2A1—breast cancer	0.000323	0.000445	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NQO1—breast cancer	0.000323	0.000445	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CD—breast cancer	0.000322	0.000444	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SERPINE1—breast cancer	0.000319	0.000439	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DLL1—breast cancer	0.000319	0.000439	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ALB—breast cancer	0.000318	0.000438	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.000316	0.000435	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP3A4—breast cancer	0.000315	0.000434	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	0.000314	0.000433	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000313	0.000431	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIST1H2BC—breast cancer	0.000313	0.000431	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIST1H2BK—breast cancer	0.000313	0.000431	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GRB7—breast cancer	0.00031	0.000427	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDE4D—breast cancer	0.00031	0.000427	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP1B1—breast cancer	0.00031	0.000426	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CSF2—breast cancer	0.000309	0.000425	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TAB2—breast cancer	0.000305	0.000419	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NOS3—breast cancer	0.000304	0.000419	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HSP90AA1—breast cancer	0.000304	0.000418	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ITPR1—breast cancer	0.000303	0.000418	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR2—breast cancer	0.000302	0.000416	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL8—breast cancer	0.000302	0.000416	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MMP3—breast cancer	0.000301	0.000415	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	0.000301	0.000414	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA1—breast cancer	0.000295	0.000407	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DKK1—breast cancer	0.000295	0.000406	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFC—breast cancer	0.000293	0.000403	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP19A1—breast cancer	0.000291	0.000401	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—STK11—breast cancer	0.000291	0.000401	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAG2—breast cancer	0.000288	0.000397	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—RAF1—breast cancer	0.000288	0.000396	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—WNT1—breast cancer	0.000284	0.000391	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PLA2G4A—breast cancer	0.000283	0.00039	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CB—breast cancer	0.000281	0.000387	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CSF2—breast cancer	0.00028	0.000386	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000273	0.000376	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—AKT1—breast cancer	0.000271	0.000374	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—COMT—breast cancer	0.000271	0.000373	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTP1—breast cancer	0.000269	0.000371	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH4—breast cancer	0.000269	0.000371	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GZMB—breast cancer	0.000268	0.000368	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HMOX1—breast cancer	0.000266	0.000366	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ITPR1—breast cancer	0.000265	0.000365	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL2—breast cancer	0.00026	0.000358	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR2—breast cancer	0.00026	0.000358	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2—breast cancer	0.000258	0.000355	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTHLH—breast cancer	0.000257	0.000354	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BMP2—breast cancer	0.000257	0.000354	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ABCB1—breast cancer	0.000255	0.000351	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TYMS—breast cancer	0.00025	0.000345	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EDNRB—breast cancer	0.000249	0.000343	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTM1—breast cancer	0.000248	0.000341	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PLA2G4A—breast cancer	0.000248	0.000341	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOR1—breast cancer	0.000248	0.000341	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PGR—breast cancer	0.000246	0.000339	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—THBS1—breast cancer	0.000245	0.000337	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GPX1—breast cancer	0.000237	0.000326	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP1A1—breast cancer	0.000235	0.000323	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FLT1—breast cancer	0.000234	0.000322	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF3—breast cancer	0.000233	0.000321	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SQSTM1—breast cancer	0.000233	0.000321	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ERCC2—breast cancer	0.000233	0.00032	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CG—breast cancer	0.000232	0.000319	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAG1—breast cancer	0.00023	0.000317	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH3—breast cancer	0.000229	0.000315	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PARP1—breast cancer	0.000229	0.000315	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CALCA—breast cancer	0.000226	0.000311	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SRC—breast cancer	0.000225	0.00031	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RPS6—breast cancer	0.000223	0.000308	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF4—breast cancer	0.000222	0.000305	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL12—breast cancer	0.000221	0.000304	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCR4—breast cancer	0.000221	0.000304	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VEGFA—breast cancer	0.000219	0.000302	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTHFR—breast cancer	0.000219	0.000301	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PAK1—breast cancer	0.000217	0.000298	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TCF7L2—breast cancer	0.000213	0.000293	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT2—breast cancer	0.000212	0.000292	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CG—breast cancer	0.00021	0.00029	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MAPK3—breast cancer	0.000207	0.000286	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH2—breast cancer	0.000205	0.000283	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HSP90AA1—breast cancer	0.000205	0.000283	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CD—breast cancer	0.000204	0.00028	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CAV1—breast cancer	0.000202	0.000278	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—breast cancer	0.000201	0.000277	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR1—breast cancer	0.0002	0.000275	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRL—breast cancer	0.0002	0.000275	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STK11—breast cancer	0.000197	0.000271	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADAM10—breast cancer	0.000197	0.000271	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PLG—breast cancer	0.000195	0.000268	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.000193	0.000265	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT2—breast cancer	0.000193	0.000265	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF10—breast cancer	0.000192	0.000264	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—KRAS—breast cancer	0.000186	0.000257	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CD—breast cancer	0.000185	0.000255	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFA—breast cancer	0.000185	0.000254	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CG—breast cancer	0.000184	0.000253	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFBR2—breast cancer	0.000182	0.000251	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ITPR1—breast cancer	0.000179	0.000247	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB4—breast cancer	0.000178	0.000245	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP3—breast cancer	0.000178	0.000245	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT5A—breast cancer	0.000178	0.000245	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CB—breast cancer	0.000178	0.000244	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SMAD4—breast cancer	0.000172	0.000237	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1R—breast cancer	0.000171	0.000236	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CA—breast cancer	0.000171	0.000236	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL8—breast cancer	0.000171	0.000235	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HES1—breast cancer	0.000168	0.000232	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NCOR1—breast cancer	0.000167	0.00023	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PLA2G4A—breast cancer	0.000167	0.00023	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TP53—breast cancer	0.000166	0.000228	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CSF2—breast cancer	0.000166	0.000228	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF1—breast cancer	0.000166	0.000228	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RAF1—breast cancer	0.000165	0.000227	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRG1—breast cancer	0.000164	0.000226	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—H2AFX—breast cancer	0.000163	0.000225	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2—breast cancer	0.000163	0.000224	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—E2F1—breast cancer	0.000162	0.000223	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CD—breast cancer	0.000162	0.000222	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CB—breast cancer	0.000161	0.000222	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ALB—breast cancer	0.00016	0.00022	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—HRAS—breast cancer	0.000158	0.000218	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SPP1—breast cancer	0.000156	0.000214	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL8—breast cancer	0.000155	0.000213	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB3—breast cancer	0.000154	0.000212	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR2—breast cancer	0.000154	0.000212	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NOS3—breast cancer	0.000153	0.00021	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2—breast cancer	0.000148	0.000204	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TERT—breast cancer	0.000148	0.000203	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR1—breast cancer	0.000143	0.000197	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIF1A—breast cancer	0.000141	0.000194	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CB—breast cancer	0.000141	0.000194	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT1—breast cancer	0.00014	0.000193	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTGS2—breast cancer	0.00014	0.000192	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LEP—breast cancer	0.000138	0.00019	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CAV1—breast cancer	0.000136	0.000188	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KDR—breast cancer	0.000135	0.000186	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ESR1—breast cancer	0.000132	0.000181	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FN1—breast cancer	0.00013	0.000179	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NFKBIA—breast cancer	0.000128	0.000177	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOTCH1—breast cancer	0.000127	0.000175	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KIT—breast cancer	0.000124	0.000171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CG—breast cancer	0.000124	0.000171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—APC—breast cancer	0.000124	0.000171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGF—breast cancer	0.000123	0.000169	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTEN—breast cancer	0.000122	0.000168	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MAPK3—breast cancer	0.000119	0.000164	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BRAF—breast cancer	0.000117	0.000161	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1—breast cancer	0.000114	0.000157	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT2—breast cancer	0.000114	0.000157	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EGFR—breast cancer	0.000113	0.000156	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CD—breast cancer	0.000109	0.00015	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CA—breast cancer	0.000108	0.000149	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SERPINE1—breast cancer	0.000108	0.000149	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—KRAS—breast cancer	0.000107	0.000147	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOS3—breast cancer	0.000103	0.000142	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CA—breast cancer	9.83e-05	0.000135	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MDM2—breast cancer	9.79e-05	0.000135	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RAF1—breast cancer	9.76e-05	0.000134	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RELA—breast cancer	9.71e-05	0.000134	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB2—breast cancer	9.65e-05	0.000133	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MTOR—breast cancer	9.53e-05	0.000131	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CB—breast cancer	9.53e-05	0.000131	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL8—breast cancer	9.15e-05	0.000126	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—HRAS—breast cancer	9.09e-05	0.000125	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1B—breast cancer	8.94e-05	0.000123	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT1—breast cancer	8.84e-05	0.000122	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CASP3—breast cancer	8.76e-05	0.000121	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2—breast cancer	8.75e-05	0.00012	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6—breast cancer	8.7e-05	0.00012	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CA—breast cancer	8.59e-05	0.000118	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCND1—breast cancer	8.53e-05	0.000117	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JUN—breast cancer	8.51e-05	0.000117	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CTNNB1—breast cancer	8.45e-05	0.000116	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—breast cancer	8.28e-05	0.000114	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1A—breast cancer	8.25e-05	0.000114	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTEN—breast cancer	8.23e-05	0.000113	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK8—breast cancer	8.05e-05	0.000111	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT1—breast cancer	8.03e-05	0.000111	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SRC—breast cancer	7.63e-05	0.000105	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFA—breast cancer	7.43e-05	0.000102	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT3—breast cancer	7.36e-05	0.000101	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAPK3—breast cancer	7.03e-05	9.68e-05	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKT1—breast cancer	7.01e-05	9.66e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—breast cancer	6.84e-05	9.42e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—breast cancer	6.82e-05	9.39e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGFR—breast cancer	6.69e-05	9.21e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KRAS—breast cancer	6.32e-05	8.7e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CA—breast cancer	5.81e-05	7.99e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TP53—breast cancer	5.62e-05	7.73e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HRAS—breast cancer	5.37e-05	7.4e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6—breast cancer	5.14e-05	7.08e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT1—breast cancer	4.74e-05	6.53e-05	CbGpPWpGaD
